about
The management of perioperative nutrition in patients with end stage liver disease undergoing liver transplantationOrally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in miceHypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight DysregulationThe orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexiaImproving survival in decompensated cirrhosisMalnutrition in end stage liver disease: recommendations and nutritional support.Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study.Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responsesWhen can nutritional therapy impact liver disease?Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.Adipokines in Liver Cirrhosis.Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.Alteration in body composition in the portacaval anastamosis rat is mediated by increased expression of myostatinRole of nutrition in the management of hepatic encephalopathy in end-stage liver failure.Incisional hernia following liver transplantation: incidence and predisposing factors.Safety of an immune-enhancing nutrition supplement in cirrhotic patients with history of encephalopathy.Nutrition and Muscle in Cirrhosis.Preoperative optimization for major hepatic resection.Letter: there is something about the Neutrophil-to-Lymphocyte ratio (NLR)…-authors' reply.Pulmonary rehabilitation improves exercise capacity and quality of life in underweight patients with chronic obstructive pulmonary disease.Changes of Intestinal Functions in Liver Cirrhosis.Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia.
P2860
Q26775631-BBA7159C-84E9-48C8-8A57-4844B062F4BEQ33419364-BB543B5C-5726-43D3-8A07-497C22A988FEQ33887434-FAF40545-D1CB-46C9-A366-49EF0DA05E94Q35223982-B4B873F8-B97D-4341-B969-11BC016CA6CAQ36090423-C7E58663-E80C-404B-8B8F-6579560A0490Q37132386-BCA7F69D-40CC-47DF-95FA-33F1DCBC404BQ37651904-54CD3A55-4357-4F25-8D1D-8A46513B996CQ37982868-76F43246-A98C-4F8B-92EC-B3A673E59CC6Q38245694-1D26D30B-70E6-46EA-8149-977600E5AA91Q38653870-1DC60599-76DE-4F4D-AA60-754F72E6FC16Q39404643-7400D701-7943-4131-B764-2E34E1BF96F3Q40395597-43BF613F-11DC-4EE6-87B5-939EBD3755AEQ41970744-B0C708C3-3274-40A2-B88E-17A103C24574Q42158270-8324A7FD-6F02-4141-A2AC-67A0D4B8EC19Q44543997-B307F401-8CF3-477D-A54D-3C8C1F61533FQ44917838-E1D5D81A-7286-42C0-AE7F-4E359FCEE2B2Q47300465-21CE9EE8-EC64-4426-BCD8-70F66436D2C6Q47389889-AD8E3AED-40D2-4120-A601-A914761717EBQ48125496-5F20587E-6404-403C-95BD-7D3F943B8D13Q48769123-0156D6DE-1612-4E79-89EE-8BFB297FBD11Q55322856-03EB5D89-A12B-454A-8DB7-DEC7BF99BCF6Q55383187-53F7800C-BF36-40A2-AA63-F5A356A27078
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cachexia in liver cirrhosis.
@ast
Cachexia in liver cirrhosis.
@en
Cachexia in liver cirrhosis.
@nl
type
label
Cachexia in liver cirrhosis.
@ast
Cachexia in liver cirrhosis.
@en
Cachexia in liver cirrhosis.
@nl
prefLabel
Cachexia in liver cirrhosis.
@ast
Cachexia in liver cirrhosis.
@en
Cachexia in liver cirrhosis.
@nl
P1476
Cachexia in liver cirrhosis.
@en
P2093
Elke-Tatjana Schütz
Mathias Plauth
P356
10.1016/S0167-5273(02)00236-X
P577
2002-09-01T00:00:00Z